Health-related quality of life after intensity modulated radiation therapy for localized prostate cancer: Comparison with conventional and conformal radiotherapy

Japanese Journal of Clinical Oncology

Volumn 36, Issue 4, 2006, Pages 224-230

  Namiki, Shunichi ^a   Ishidoya, Shigeto ^a   Tochigi, Tatsuo ^b   Kawamura, Sadafumi ^b   Kuwahara, Masaaki ^b   Terai, Akito ^c   Yoshimura, Koji ^c   Numata, Isao ^d   Satoh, Makoto ^a   Saito, Seiichi ^a   Takai, Yoshihiro ^e   Yamada, Shogo ^a   Arai, Yoichi ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Miyagi Cancer Center   (Japan)

^c KURASHIKI CENTRAL HOSPITAL   (Japan)

^d Furukawa City Hospital   (Japan)

^e TOHOKU UNIVERSITY   (Japan)

Author keywords

Conformal radiation therapy; Conventional radiotherapy; Intensity modulated radiation therapy; Prostate cancer; Quality of life

Indexed keywords

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CLINICAL OBSERVATION; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; HEALTH SURVEY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; INTESTINE FUNCTION DISORDER; MAJOR CLINICAL STUDY; MALE; MICTURITION; OUTCOME ASSESSMENT; PROSTATE CANCER; QUALITY OF LIFE; SEXUAL DYSFUNCTION; STATISTICAL SIGNIFICANCE;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; HEALTH STATUS; HUMANS; IMPOTENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; TREATMENT OUTCOME; URINATION DISORDERS;

EID: 33745686440     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyl002     Document Type: Article

References (31)

1. The Research Group for Population-Based Cancer Registration in Japan. Cancer incidence and incidence rates in Japan in 1995: Estimates based on data from nine population-based cancer registries. Jpn J Clin Oncol 2000;30: 318-21.
2. Bill-Axelson A, Holmberg L, Ruutu M, Haggman M, Andersson SO, Bratell S, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2005;352:1977-84.
3. Potters L, Klein EA, Kattan MW, Reddy CA, Ciezki JP, Reuther AM, et al. Monotherapy for stage T1-T2 prostate cancer: Radical prostatectomy, external beam radiotherapy, or permanent seed implantation. Radiother Oncol 2004;71:29-33.
4. Litwin MS, Hays RD, Fink A, Ganz PA, Leak B, Leach GE et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 1995;273:129-35.
5. Shrader-Bogen CL, Kjellberg JL, McPherson CP, Murray CL. Quality of life and treatment outcomes. Cancer 1997;79:1977-86.
6. Hanks GE, Martz KL and Diamond JJ. The effect of dose on local control of prostate cancer. Int J Radiat Oncol Biol Phys 1988;15: 1299-305.
7. Pollack A and Zagars GK. External beam radiotherapy dose-response of prostate cancer. Int J Radiat Oncol Biol Phys 1997;39: 1011-8.
8. Smit WG, Helle PA, van Putten WL, Wijnmaalen AJ, Seldenrath JJ, van der Werf-Messing BH. Late radiation damage in prostate cancer patients treated by high dose external radiotherapy in relation to rectal dose. Int J Radiat Oncol Biol Phys 1990;18:23-9.
9. Zelefsky MJ, Fuks Z, Hunt M, Lee HJ, Lombardi D, Ling CC, et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol 2001;166:876-81.
10. Zelefsky MJ, Fuks Z, Hunt M, Yamada Y, Marion C, Ling CC, et al. High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 2002;53:1111-6.
11. Potosky AL, Legler J, Albertsen PC, Stanford JL, Gilliland FD, Hamilton AS, et al. Health outcomes after prostatectomy or radiotherapy for prostate cancer: Results from the Prostate Cancer Outcomes Study. J Natl Cancer Inst 2000;92:1582-92.
12. Takai Y, Mitsuya M, Nemoto K, Ogawa Y, Matsushita H, Yamada S, et al. Development of a new linear accelerator mounted with dual fluoroscopy using amorphous silicon flat panel X-ray sensors to detect a gold seed in a tumor at real treatment position. Int J Radiat Oncol Biol Phys 2001;51(Suppl):381.
13. Britton KR, Takai Y, Mitsuya M, Nemoto K, Ogawa Y, Yamada S. Evaluation of inter- and intrafraction organ motion during intensity modulated radiation therapy (IMRT) for localized prostate cancer measured by a newly developed on-board image-guided system. Radiat Med 2005;23:14-24.
14. Hays RD, Sherbourne CD, Mazel RM. The RAND 36-Item Health Survey 1.0. Health Econ 2:217-227, 1993.
15. Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Brook RH. The UCLA Prostate Cancer Index: Development, reliability, and validity of a health-related quality of life measure. Med. Care 1998;36: 1002-12.
16. Fukuhara S, Ware Je, Koshinski M. Psychometric and clinical tests of validity of the Japanese SF-36 health survey. J. Clin Epidemiol 1998;51:1045-53.
17. Kakehi Y, Kamoto T, Ogawa O, Arai Y, Litwin MS, Suzukamo Y, et al. Development of Japanese version of the UCLA Prostate Cancer Index: A pilot validation study. Int J Clin Oncol 2002;7:306-11.
18. Lubeck DP, Litwin MS, Henning JM, Stoddard ML, Flanders SC, Carroll PR. Changes in health-related quality of life in the first year after treatment for prostate cancer. Urology 1999;53:180-86.
19. Hamilton AS, Stanford JL, Gilliland FD, Albertsen PC, Stephenson RA, Hoffman RM, et al. Health outcomes after external-beam radiation therapy for clinically localized prostate cancer: Results from the Prostate Cancer Outcomes Study. J Clin Oncol 2001 19: 2517-26.
20. Beard CJ, Propert KJ, Rieker PP, Clark JA, Kaplan I, Kantoff PW, et al. Complications after treatment with extemal-beam irradiation in early-stage prostate cancer patients: A prospective multimstitutional outcomes study. J Clin Oncol 1997;15:223-9.
21. Talcott JA, Rieker P, Clark JA, Propert. KJ, Weeks JC, Beard CJ, et al. Patient-reported symptoms after primary therapy for early prostate cancer: Results of a prospective cohort study. J Clin Oncol 1998;16:275-83.
22. Fowler FJ Jr, Barry MJ, Lu-Yao G, Wasson JH, Bin L. Outcomes of external-beam radiation therapy for prostate cancer: A study of Medicare beneficiaries in three surveillance, epidemiology, and end results areas. J Clin Oncol 1996;14:2258-65.
23. Litwin MS, Pasta DJ, Yu J, Stoddard ML, Flanders SC. Urinary function and bother after radical prostatectomy or radiation for prostate cancer: a longitudinal, multivariate quality of life analysis from the Cancer of the Prostate Strategic Urologic Research Endeavor. J Urol 2000;164:1973-7.
24. Wei TW, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the Expanded Prostate Cancer Index Composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 2000;56:888-905.
25. Takegami M, Suzakamo Y, Sanda MG, Kamoto T, Namiki S, Arai Y, et al. The Japanese translation and cultural adaptation of Expanded Prostate Cancer Index (EPIC). Nippon Hinyokika Gakkai Zasshi 2005;96:657-69.
26. Davis JW, Kuban DA, Lynch DF, Schellhammer PF. Quality of life after treatment for localized prostate cancer: Differences based on treatment modality. J Urol 2001;166:947-52.
27. Bacon CG, Giovannucci E, Testa M, Kawachi I. The impact of cancer treatment on quality of life outcomes for patients with localized prostate cancer. J Urol 2001;166:1804-10.
28. Namiki S, Tochigi T, Kuwahara M, Ioritani N, Terai A, Numata I, et al. Health related quality of life in Japanese men after radical prostatectomy or radiation therapy for localized prostate cancer. Int J Urol 2004;11:619-27.
29. Litwin MS, Flanders SC, Pasta DJ, Stoddard ML, Lubeck DP, Henning JM. Sexual function and bother after radical prostatectomy or radiation for prostate cancer: Multivariate quality-of-life analysis from CaPSURE. Urology 1999;54:503-8.
30. Beckendorf V, Hay M, Rozan R, Lagrange JL, N'Guyen T, Giraud B. Changes in sexual function after radiotherapy treatment of prostate cancer. Br J Urol 1996, 77:118-23.
31. Masumori N, Tsukamoto T, Kumamoto Y, Panser LA, Rhodes T, Girman CJ, et al. Decline of sexual function with age in Japanese men compared with American men: Results of two community-based studies. Urology 1999;54:335-45.